|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Stock-based compensation, net of amounts capitalized | |||||
| Non-cash lease expense | |||||
| Accretion of discount on marketable securities, net | |||||
| Net loss on sale of marketable securities | |||||
| Amortization of deferred contract costs | |||||
| Change in fair value of contingent earn-out consideration liability | |||||
| Impairment of long-lived assets | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of effect of acquisition: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Deferred contract costs | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Cash paid for acquisition, net of cash acquired | |||||
| Purchases of property and equipment | |||||
| Purchases of intangible assets | |||||
| Internal-use software development costs | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Sales of marketable securities | |||||
| Other | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions | |||||
| Proceeds from issuance of common stock upon exercise of stock options and common stock warrants | |||||
| Proceeds from issuance of common stock in connection with the employee stock purchase plan | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Repurchase of common stock | |||||
| Payment of contingent consideration related to a business combination | |||||
| Payments of deferred offering costs | |||||
| Payment of excise taxes on share repurchases | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for taxes, net of refunds | |||||
| Non-cash financing and investing activities | |||||
| Conversion of redeemable convertible preferred stock to common stock | |||||
| Fair value of contingent earn-out consideration included in purchase consideration | |||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Repurchase included in accrued expenses | |||||
| Equity awards included in purchase consideration | |||||
| Capitalized stock-based compensation for internal-use software development costs | |||||
| Excise tax payable on share repurchases | |||||
Loading...